Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 27% ± 10% | |
ciliated cell | 6 studies | 23% ± 7% | |
macrophage | 6 studies | 25% ± 6% | |
epithelial cell | 5 studies | 36% ± 13% | |
fibroblast | 5 studies | 20% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 24% ± 8% | |
myeloid cell | 4 studies | 21% ± 3% | |
basal cell | 4 studies | 27% ± 9% | |
abnormal cell | 4 studies | 28% ± 9% | |
type II pneumocyte | 4 studies | 21% ± 6% | |
astrocyte | 4 studies | 28% ± 6% | |
goblet cell | 4 studies | 25% ± 13% | |
classical monocyte | 3 studies | 21% ± 3% | |
hematopoietic precursor cell | 3 studies | 20% ± 3% | |
microglial cell | 3 studies | 25% ± 2% | |
lymphocyte | 3 studies | 20% ± 2% | |
GABAergic neuron | 3 studies | 41% ± 6% | |
glutamatergic neuron | 3 studies | 52% ± 6% | |
dendritic cell | 3 studies | 27% ± 5% | |
endothelial cell of lymphatic vessel | 3 studies | 20% ± 5% | |
transit amplifying cell | 3 studies | 28% ± 11% | |
erythroblast | 3 studies | 22% ± 4% | |
oligodendrocyte | 3 studies | 24% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7916.53 | 1445 / 1445 | 100% | 107.27 | 183 / 183 |
intestine | 100% | 7586.35 | 966 / 966 | 100% | 72.70 | 527 / 527 |
ovary | 100% | 10113.21 | 180 / 180 | 100% | 125.66 | 430 / 430 |
skin | 100% | 11065.37 | 1809 / 1809 | 100% | 121.75 | 472 / 472 |
stomach | 100% | 5682.47 | 359 / 359 | 100% | 77.80 | 286 / 286 |
lung | 100% | 9931.03 | 578 / 578 | 100% | 90.89 | 1154 / 1155 |
prostate | 100% | 8256.98 | 245 / 245 | 100% | 66.84 | 501 / 502 |
uterus | 100% | 9589.71 | 170 / 170 | 100% | 85.60 | 458 / 459 |
thymus | 100% | 9424.19 | 653 / 653 | 100% | 68.46 | 603 / 605 |
breast | 100% | 9141.16 | 459 / 459 | 100% | 119.42 | 1114 / 1118 |
bladder | 100% | 8589.10 | 21 / 21 | 100% | 73.09 | 502 / 504 |
brain | 99% | 5494.35 | 2626 / 2642 | 100% | 77.76 | 705 / 705 |
pancreas | 100% | 3925.97 | 328 / 328 | 99% | 59.63 | 176 / 178 |
kidney | 100% | 6292.10 | 89 / 89 | 97% | 51.52 | 878 / 901 |
adrenal gland | 100% | 8083.80 | 258 / 258 | 96% | 52.40 | 220 / 230 |
liver | 100% | 3666.35 | 226 / 226 | 93% | 46.83 | 377 / 406 |
adipose | 100% | 9040.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8144.43 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 73.97 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 74.28 | 29 / 29 |
muscle | 100% | 7234.91 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7746.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 77.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.78 | 1 / 1 |
heart | 98% | 5751.14 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 6564.04 | 903 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007339 | Biological process | binding of sperm to zona pellucida |
GO_0062029 | Biological process | positive regulation of stress granule assembly |
GO_0034063 | Biological process | stress granule assembly |
GO_0061484 | Biological process | hematopoietic stem cell homeostasis |
GO_0031519 | Cellular component | PcG protein complex |
GO_0005694 | Cellular component | chromosome |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | UBAP2L |
Protein name | Ubiquitin associated protein 2 like Ubiquitin-associated protein 2-like (Protein NICE-4) (RNA polymerase II degradation factor UBAP2L) |
Synonyms | KIAA0144 NICE4 |
Description | FUNCTION: Recruits the ubiquitination machinery to RNA polymerase II for polyubiquitination, removal and degradation, when the transcription-coupled nucleotide excision repair (TC-NER) machinery fails to resolve DNA damage . Plays an important role in the activity of long-term repopulating hematopoietic stem cells (LT-HSCs) (By similarity). Required for efficient formation of stress granules . . |
Accessions | Q5VU81 ENST00000412596.5 Q5VU78 ENST00000437652.6 ENST00000707139.1 H7C2T8 Q5VU77 Q5VU79 ENST00000343815.10 [Q14157-1] Q14157 ENST00000368504.6 ENST00000361546.6 [Q14157-2] F8W726 ENST00000613315.4 [Q14157-4] ENST00000456325.5 ENST00000433615.5 ENST00000441890.5 ENST00000428931.6 [Q14157-2] ENST00000271877.11 A0AA34QVE6 ENST00000428595.1 H0Y5H6 Q5VU80 |